COVID-19: Post-recovery Manifestations
暂无分享,去创建一个
Farhat Jahan | S. Shaikh | Zainab Mehkari | Zunaira Siddiqi | Crystal Ukachukwu | S. Khan | Ketan Pamurthy | Amaiya Brown
[1] M. Theodoridou,et al. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals , 2021, Archives of Medical Research.
[2] C. Fernández‐de‐las‐Peñas,et al. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification , 2021, International journal of environmental research and public health.
[3] C. Ryerson,et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea , 2021, Respiratory Physiology & Neurobiology.
[4] Liang Wang,et al. Demographic, signs and symptoms, imaging characteristics of 2126 patients with COVID-19 pneumonia in the whole quarantine of Wuhan, China , 2021, Clinical Imaging.
[5] Felipe García,et al. Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain , 2021, The Lancet Regional Health - Europe.
[6] A. Komaroff,et al. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? , 2021, Frontiers in Medicine.
[7] P. Wostyn. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? , 2021, Medical Hypotheses.
[8] E. Wood,et al. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.
[9] K. Dua,et al. Smoking and COVID-19: What we know so far , 2020, Respiratory Medicine.
[10] N. Marx,et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae , 2020, Respiratory Medicine.
[11] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[12] R. Chang,et al. Sickness: From the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons , 2015, Neuroscience & Biobehavioral Reviews.
[13] T. Ganiats. Redefining the Chronic Fatigue Syndrome , 2015, Annals of Internal Medicine.
[14] ChronicFatigue Syndrome. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome , 2015 .
[15] R. Dantzer,et al. The neuroimmune basis of fatigue , 2014, Trends in Neurosciences.
[16] K. Friedman. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. , 2015, Military medicine.
[17] A. Aplogan,et al. From the Centers for Disease Control and Prevention , 2015 .
[18] M. Vella-Baldacchino,et al. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) , 2014 .
[19] D. McGinty,et al. Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME/CFS) , 2007 .